ZA929513B - Benzofurans. - Google Patents

Benzofurans.

Info

Publication number
ZA929513B
ZA929513B ZA929513A ZA929513A ZA929513B ZA 929513 B ZA929513 B ZA 929513B ZA 929513 A ZA929513 A ZA 929513A ZA 929513 A ZA929513 A ZA 929513A ZA 929513 B ZA929513 B ZA 929513B
Authority
ZA
South Africa
Prior art keywords
benzofurans
Prior art date
Application number
ZA929513A
Other languages
English (en)
Inventor
Werner Mederski
Horst Juraszyk
Norbert Beier
Pierre Schilling
Ingeborg Lues
Klaus Otto Minck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA929513B publication Critical patent/ZA929513B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA929513A 1991-12-09 1992-12-08 Benzofurans. ZA929513B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4140519A DE4140519A1 (de) 1991-12-09 1991-12-09 Benzofurane

Publications (1)

Publication Number Publication Date
ZA929513B true ZA929513B (en) 1993-06-15

Family

ID=6446602

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA929513A ZA929513B (en) 1991-12-09 1992-12-08 Benzofurans.

Country Status (10)

Country Link
EP (1) EP0546449A3 (ja)
JP (1) JPH05262768A (ja)
AU (1) AU2993792A (ja)
CA (1) CA2084736A1 (ja)
DE (1) DE4140519A1 (ja)
HU (1) HU9203893D0 (ja)
MX (1) MX9207070A (ja)
NO (1) NO924745L (ja)
PL (1) PL296865A2 (ja)
ZA (1) ZA929513B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920021542A (ko) * 1991-05-16 1992-12-18 배리 안토니 뉴샘 벤조푸란 유도체
GB9110636D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
DE4324580A1 (de) * 1993-07-22 1995-01-26 Thomae Gmbh Dr K Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19845153A1 (de) * 1998-10-01 2000-04-06 Merck Patent Gmbh Imidazo[4,5]-pyridin-4-on-derivate
EP1724271A4 (en) 2004-02-26 2013-01-23 Kyowa Hakko Kirin Co Ltd PREVENTIVE AND / OR THERAPEUTIC AGENT AGAINST NEUTROPHIC INFLAMMATORY DISEASE
WO2023210623A1 (ja) * 2022-04-28 2023-11-02 株式会社エス・ディー・エス バイオテック ハロアルキルスルホンアニリド化合物及びそれらを含有する除草剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
GB8927277D0 (en) * 1989-12-01 1990-01-31 Glaxo Group Ltd Chemical compounds
KR920021542A (ko) * 1991-05-16 1992-12-18 배리 안토니 뉴샘 벤조푸란 유도체

Also Published As

Publication number Publication date
NO924745L (no) 1993-06-10
DE4140519A1 (de) 1993-06-17
EP0546449A3 (en) 1993-07-14
MX9207070A (es) 1993-06-01
NO924745D0 (no) 1992-12-08
HU9203893D0 (en) 1993-03-29
PL296865A2 (en) 1993-06-14
CA2084736A1 (en) 1993-06-10
EP0546449A2 (de) 1993-06-16
AU2993792A (en) 1993-06-10
JPH05262768A (ja) 1993-10-12

Similar Documents

Publication Publication Date Title
DE69107059D1 (en) Sigma-delta-modulator.
ZA92908B (en) Compounds.
AR244753A1 (es) Azocolorantes.
ZA926733B (en) 1,2-Dihydro-2-oxopyridines.
DE69111595D1 (en) Squarylium- und crokonyliumfarbstoffe.
DE69104185D1 (en) Luftreservoir.
DE69112211D1 (en) Luftreinigungsvorrichtung.
ZA929517B (en) Compounds.
DE59204008D1 (en) Trachealstent.
ZA926482B (en) Cyanophenylpyrroles.
DE69106281D1 (en) Phenanthrenderivat.
ZA927792B (en) Anti-alpha6-integrin-antibodies.
ZA928649B (en) Brakes.
ZA929590B (en) Diphenylsulphides.
DE69102644D1 (en) Demodulationsreferenzsignalquelle.
OA09716A (en) Benzoxaiole derivatives.
EP0576606A4 (en) RESIDUAL PROTEASE-III.
DE69114491D1 (en) Olefincopolymere.
DE69110012D1 (en) Linienerkennungsverfahren.
DE69205795D1 (en) Mesoprotheseunterlage.
ZA925185B (en) Dithianes.
EP0572573A4 (en) Thyroid-derived chondrocyte-stimulating factor.
ZA926706B (en) Heterocyclically substituted quinolylmethoxy-phenylacetamides.
DE69203865D1 (en) Thermo-transferdrucksystem.
ZA929513B (en) Benzofurans.